Navigation Links
NYU Steinhardt researchers to study why male millennials risk HIV transmission
Date:4/28/2014

The number of new HIV infections in the United States had remained steady in recent years, but rates among urban millennial gay, bisexual, and other young men who have sex with men (YMSM) have steadily increased in the past decade.

New York University researchers, led by Perry Halkitis, a professor at the Steinhardt School of Culture, Education, and Human Development, the Global Institute of Public Health, and NYU Langone Medical Center, will study this population in order to better understand the reasons for this increase under a five-year, $3.1 million grant from the National Institute on Drug Abuse, part of the National Institutes of Health.

The research is a continuation of a study of young men that began in 2009 under the name Project 18 (P18).

"The goal of this project is to understand why a new generation of YMSM place themselves at risk for HIV transmission," explains Halkitis, who is also associate dean for academic affairs at NYU's Global Institute of Public Health. "We aim to understand why some men exhibit risky behaviors as they emerge into adulthood while others do not."

The project's other researchers include three faculty in NYU Steinhardt's Public Health programFarzana Kapadia, the primary co-investigator, Danielle Ompad, and Rafael Perez Figueroaas well as Richard Greene, an assistant professor at NYU Langone Medical Center.

YMSM include not only gay men, but also those who are bisexual and heterosexual men but who have had sex with other men but do not identify as gay or bisexual.

Under the grant, the research team will continue its cohort study of nearly 600 racially, ethnically, and socioeconomically diverse YMSM that began when the subjects were in their late teens and who are now in their early 20s. The study will also expand this cohort and recruit some 300 additional men who are also now in their early 20s.

The study will consider several factors that may explain the rise in incidence rates, ranging from the behavioral to the structural, including the social and sexual networks of YMSM, the role of homophobia and discrimination in society, and the presence of other sexually transmitted infectionsas well as substance use and mental health burdens.

In addition, the researchers will consider the factors that explain both resilience and riskwhy some acquire HIV while others do not and how does the development of sexual risk coincide with other health conditions. The goal, they explain, is to move away from a program of research focused solely on deficit models and to also consider how new biomedical technologies such as PrEP (pre exposure prophylaxis) affect HIV health in a new generation of men.

Armed with greater insights into the factors that lead to growing rates of HIV among this population, the researchers will seek to create ways to address it, in part, as informed by the effective strategies some young men are utilizing.

"Working with community and municipal partners, we will draw from what we have learned to develop strategies for HIV prevention and intervention that are relevant to this current and developing generation who did not live through the devastation of the AIDS epidemic in the 1980s," says Halkitis.


'/>"/>

Contact: James Devitt
james.devitt@nyu.edu
212-998-6808
New York University
Source:Eurekalert

Related medicine news :

1. More alcohol and traffic laws mean fewer traffic deaths, NYU Steinhardt study concludes
2. Researchers generate immunity against tumor vessel protein
3. Researchers at LSTM part of the international team to sequence the tsetse genome
4. Oxygen diminishes the hearts ability to regenerate, researchers discover
5. Finnish team of researchers finds a mutation in a tumor of the jaw
6. Depressed? Researchers identify new anti-depressant mechanisms, therapeutic approaches
7. Life stressors trigger neurological disorders, researchers find
8. Penn researchers find link between sleep and immune function in fruit flies
9. Penn Medicine researchers uncover hints of a novel mechanism behind general anesthetic action
10. CU researchers discover target for treating dengue fever
11. BUSM researchers find anti-seizure drug may reduce alcohol consumption
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... IsoComforter, Inc. ... products, announced today the introduction of an innovative new design of the shoulder pad. ... so you get maximum comfort while controlling your pain while using cold therapy. By ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, a ... health care, have expanded their existing home health joint venture through an agreement, ... been operating a joint venture home health company with Asante, delivering clinically integrated ...
(Date:10/12/2017)... ... October 12, 2017 , ... Dr. Parsa Mohebi, the Los ... article to the newly revamped Cosmetic Town journal section, featuring articles ... procedure known as Follicular Unit Extraction (FUE). , Dr. Mohebi says ...
(Date:10/12/2017)... Washington, D.C. (PRWEB) , ... October 12, 2017 , ... ... of their peers in Washington, D.C., for the 49th Congress of the International ... Ph.D ., Vice President of the Center for Cancer and Blood Disorders ...
(Date:10/12/2017)... RAPIDS, Mich. (PRWEB) , ... October 12, 2017 ... ... Wellness, has been named one of Michigan’s 2017 Best and Brightest in Wellness® ... and Brightest in Wellness® awards program on Friday, Oct. 20 from 7:30 a.m. ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... 12, 2017 AVACEN Medical , Inc. (AVACEN) ... their  2017 New Product Innovation Award for Its fibromyalgia ... and secondary medical device market research by Frost & Sullivan,s ... OTC, drug-free pain relief product, the AVACEN 100, offers a ... fibromyalgia widespread pain. ...
(Date:10/11/2017)... 2017  Caris Life Sciences ® , a leading ... of precision medicine, today announced that St. Jude Medical ... Alliance™ (POA) as its 17 th member. Through ... Crosson Cancer Institute will help develop standards of care ... profiling, making cancer treatment more precise and effective. ...
(Date:10/10/2017)... --  West Pharmaceutical Services, Inc. (NYSE: WST), a ... today shared the results of a study highlighting the ... administration of polio vaccines. The study results were presented ... by Dr. Ondrej Mach , Clinical Trials and ... and recently published in the journal Vaccine. i ...
Breaking Medicine Technology: